QuickView for u5 snrnp (biogroup)

1. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

1. TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation.
2. Mechanism for Aar2p function as a U5 snRNP assembly factor.
3. DHX15-independent roles for TFIP11 in U6 snRNA modification, U4/U6.U5 tri-snRNP assembly and pre-mRN…
4. Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.
5. The 35S U5 snRNP Is Generated from the Activated Spliceosome during In vitro Splicing.

There were no clinical trials for u5 snrnp